Beclomethasone dipropionate MDI

DRUG2 trials

Sponsors

Teva Branded Pharmaceutical Products R&D, Inc.

Conditions

AsthmaPharmacokinetics

Phase 1

A Study to Investigate the Pharmacokinetics and Safety of Beclomethasone Dipropionate Administered by Breath-Actuated Inhaler and Metered-Dose Inhaler in Healthy Adults

CompletedNCT02030457

Teva Branded Pharmaceutical Products R&D, Inc.Pharmacokinetics

Start: 2013-12-31End: 2014-06-30Updated: 2021-11-09

Phase 3

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma

CompletedNCT02040766

Teva Branded Pharmaceutical Products R&D, Inc.Asthma

Start: 2013-12-31End: 2016-03-31Updated: 2021-11-09